1/9/2014 8:05:02 AM
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced it has entered into a multi-year licensing agreement with Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, related to the use of Illumina’s next-generation sequencing technology for clinical laboratory testing.
Help employers find you! Check out all the jobs and post your resume.
comments powered by